MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    REM sleep behaviour disorder in Parkinson’s disease: prevalence and correlation with other sleep parameters

    S. Diaconu, L. Ungureanu, A. Zarnoveanu, B. Ciopleias, V. Vasile, A. Iacob, T. Moldovan, C. Falup-Pecurariu (Brasov, Romania)

    Objective: to assess the prevalence of probable rapid eye movement (REM) sleep behavior disorder (RBD) in Parkinson’s disease (PD) patients and its correlation with other…
  • 2023 International Congress

    10 year longitudinal change in clinical and biological characteristics of sporadic Parkinson Disease PPMI cohort

    P. Gonzalez-Latapi, T. Simuni, A. Siderowf, J. Fedler, M. Brumm, C. Gochanour, C. Coffey, K. Marek (Chicago, USA)

    Objective: To present data on 10 year longitudinal clinical and biological characteristics of sporadic Parkinson Disease (sPD) participants in the Parkinson’s Progression Markers Initiative (PPMI)…
  • 2023 International Congress

    Improvement of short-term satisfaction with life and treatment in Parkinson´s disease after subthalamic stimulation

    A. Sauerbier, P. Bachon, L. Ambrosio, P. Loehrer, A. Rizos, S. Jost, A. Gronostay, G. Fink, K. Ashkan, C. Nimsky, V. Visser-Vandewalle, K. Ray Chaudhuri, L. Timmermann, P. Martinez-Martin, H. Dafsari (Köln, Germany)

    Objective: The main aim of this study was to test the hypothesis that STN-DBS improves satisfaction with life and treatment in PD. Background: Subthalamic stimulation…
  • 2023 International Congress

    cerebellar cognitive affective syndrome is frequent in rfc1-related disorder

    C. Lobo, NB. Santos, F. Lima, T. Rezende, PC. Matos, JL. Pedroso, O. Barsottini, W. Marques Jr, M. França Jr (Campinas, Brazil)

    Objective: To describe the prevalence and clinical profile of cerebellar cognitive affective syndrome (CCAS) in patients with RFC1-related disorder. Background: Since the recent description of…
  • 2023 International Congress

    National Luxembourg Sleep Study: An enriched, at risk, prodromal Parkinson’s Disease cohort

    D. Mcintyre, L. Pavelka, C. Pauly, G. van Cutsem, O. Tsurkalenko, T. Marques, C. Gomes, S. Jonsdottir, J. Welch, K. Gunter, G. Aguayo, A. Sharify, E. Rosalès-Jubal, M. Vaillant, V. Satagopam, S. Ghosh, C. Vega Moreno, K. Roomp, A. Pincherle, M. Gantenbein, N. Diederich, M. Hu, R. Krüger, L. Vilas Boas (Luxembourg, Luxembourg)

    Objective: To identify a cognitively intact enriched cohort of people with isolated rapid eye movement (iREM) sleep behaviour disorder (iRBD) and hyposmia, at risk of…
  • 2023 International Congress

    Serotonin Coma: An Antipodal emergency

    K C. Chudasama, V J. Jhala (Rajkot, India)

    Objective: To highlight the severity of Serotonin syndrome precipitated in a Psychiatric patient on two unique serotonergic medications leading to a comatose state. Background: Serotonin…
  • 2023 International Congress

    Impaired mitochondrial respiration as a peripheral tissue biomarker for stratifying idiopathic Parkinson’s disease

    S. Kverneng, K. Stige, H. Berven, S. Mostafavi, M. Brischigliaro, B. Brakedal, G. Skeie, G. Nido, I. Flønes, E. Fernandez-Vizarra, C. Dölle, C. Tzoulis (Bergen, Norway)

    Objective: To determine whether structural and/or functional deficiencies of the mitochondrial respiratory chain (MRC) occur in the skeletal muscle of patients with idiopathic Parkinson’s disease…
  • 2023 International Congress

    Relationship between bradykinesia and cognitive functions in patients with essential tremor

    G. Paparella, L. Angelini, R. Margiotta, A. Cannavacciuolo, D. Costa, D. Birreci, M. de Riggi, M. Passaretti, D. Alunni Fegatelli, A. Berardelli, M. Bologna (Pozzilli, Italy)

    Objective: To investigate the association between bradykinesia, i.e., movement slowness, as objectively assessed with kinematic analysis, and cognitive functions in ET. Background: Bradykinesia in essential…
  • 2023 International Congress

    Evaluating continuous monitoring in Parkinson’s disease through real-world, device-reported outcomes.

    G. Rigas, N. Kostikis, A. Ntanis, F. Kanellos, K. Tsamis, S. Konitsiotis, D. Fotiadis (Ioannina, Greece)

    Objective: This work presents an analysis of real-world, device-reported outcomes from patients in Greece, following a 6-month, continuous telemonitoring paradigm for Parkinson's disease. Results show…
  • 2023 International Congress

    Orthostatic hypotension exacerbates gray matter atrophy related to REM sleep behavior disorder in de novo Parkinson’s disease

    T. Shiraishi, T. Umehara, Y. Iguchi (Tokyo, Japan)

    Objective: As the previous studies indicated that other factors including REM sleep behavior disorder (RBD) and olfactory dysfunction were also associated with cognitive decline and…
  • « Previous Page
  • 1
  • …
  • 292
  • 293
  • 294
  • 295
  • 296
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley